SCHEMBL20122481

SCHEMBL20122481

CC(C)C(=O)OCOC(=O)SC[C@H](NC(=O)C(C)(C)SC(=O)OCOC(=O)C(C)C)C(=O)OCc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSK P43235 5/20 0.38
▸ MME P08473 1/20 0.36
▸ ANPEP P15144 1/20 0.36
▸ CTSB P07858 2/20 0.36
▸ TACR1 P25103 1/20 0.35
▸ PPARA Q07869 2/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ ABCC3 O15438 1/20 0.35
▸ NR1I2 O75469 1/20 0.35
▸ ABCB11 O95342 1/20 0.35
▸ NR3C1 P04150 1/20 0.35
▸ RARG P13631 1/20 0.35
▸ CNR1 P21554 1/20 0.35
▸ OPRK1 P41145 1/20 0.35
▸ NR1H2 P55055 1/20 0.35
▸ NR1H3 Q13133 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122488 0.91 ALDH1A1 (0.42) CTSKMMEANPEPCTSBTACR1
SCHEMBL20122387 0.90 PPARA (0.37) CTSKMMEANPEPCTSBTACR1
SCHEMBL20122583 0.90 MME (0.36) CTSKMMEANPEPCTSBTACR1
SCHEMBL20122394 0.89 KMT2A (0.42) CTSKMMEANPEPTACR1PPARA
SCHEMBL20122417 0.89 CTRB1 (0.39) CTSKMMEANPEPCTSBTACR1
SCHEMBL20122362 0.89 ACE (0.42) CTSKMMEANPEPCTSBTACR1
SCHEMBL20122520 0.87 — —
SCHEMBL20122507 0.87 ELANE (0.35) CYP1A2ACEIDO1
SCHEMBL20122516 0.83 ADRB2 (0.41) PPARACYP2D6IDO1PPARG
SCHEMBL20122591 0.83 CYP1A2 (0.37) CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963428-B1 Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2018-05-08 — — US disclosed
Send feedback